COVID-19 and congenital, structural and valvar heart disease interventions
Friday 5 June 2020 from 16:00 CEST
Moderator: Shakeel Qureshi, Evelina Children's Hospital, London, UK
Panelist: Horst Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany
Q&A facilitators: Sameer Gafoor, Swedish Heart and Vascular Institute, Seattle, USA
Kolja Sievert, CardioVascular Center Frankfurt CVC, Frankfurt, Germany
PROGRAM
Kawasaki disease and pediatric multisystem inflammatory syndrome (PMIS)
>> Simona Marcora, Papa Giovanni XXIII Hospital, Bergamo, Italy
Potential role of ASD and PFO in embolic events
>> Bernhard Meier, Inselspital, Bern, Switzerland
Myocarditis: incidence, diagnosis and management
>> Heinz-Peter Schultheiss, Institut Kardiale Diagnostik und Therapie (IKDT), Berlin, Germany
Advanced cardiovascular support in Covid-19 patients
>> Eric Gnall, Lankenau Institute for Medical Research, Philadelphia, USA
Managing a congenital, structural and valvar cathlab during and after Covid-19
>> Mario Carminati, I.R.C.C.S. Policlinico San Donato, Milan, Italy
>> Keyhan Sayadpour, Tehran University of Medical Sciences, Tehran, Iran
Supported by:
